RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults.

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial – JAMA

Commentary: China’s Sinopharm Publishes Awaited Covid Vaccine Study Details – Bloomberg

Commentary on Twitter (thread – click for more)

The #4Humanity phase 3 trial of Sinopharm's Beijing & Wuhan vaccines published in JAMA by @NawalAlKaabi &co https://t.co/ldgUDZ9YTX HT @swiftshoes

WIV04 = Wuhan: efficacy 14 days+ after dose 2, 72.8% (58-82)
HB02 = Beijing: 78.1% (65-86)
Control group was vax adjuvant …1/n pic.twitter.com/AktyTQNoxI

— Hilda Bastian, PhD (@hildabast) May 26, 2021